Citius Oncology, Inc. (CTOR) — Defensive Interval Ratio

Latest as of December 2025: 33 days

Citius Oncology, Inc. (CTOR) has a Defensive Interval Ratio of 33 days as of December 2025. Defensive assets of $4.05 Million (cash $-, short-term investments $-, receivables $4.05 Million) cover 33 days of daily cash needs of $122.49K/day. Check CTOR goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

33 days
Days of operational coverage

Defensive Assets

$4.05 Million
Cash + ST Investments + Receivables

Daily Cash Need

$122.49K
Current Liabilities ÷ 365

Current Liabilities

$44.71 Million
USD

Annual Defensive Interval Ratio for Citius Oncology, Inc. (None–None)

The table below presents the year-by-year Defensive Interval Ratio for Citius Oncology, Inc. from None to None, covering 0 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Citius Oncology, Inc. market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)